Syngenta earnings fall as ChemChina deal advances

Syngenta CEO says takeover to be completed by end of year, but falling stock points to regulatory concern over deal.

Syngenta chief executive officer John Ramsay said on a call with analysts Wednesday that the merger deal with ChemChina is still on track and is expected to be completed by the end of the year, including all regulatory approvals.

The process for gaining approval from regulators is moving according to the company's original time table, Ramsay said. However, he declined to specify whether an application has been filed to the Committee on Foreign Investment in the U.S (CFIUS).

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.